, Tracking Stock Market Picks
Enter Symbol:
Illumina, Inc. (ILMN) [hlAlert]

up 6.70 %

Illumina, Inc. (ILMN) rated Buy with price target $175 by Stifel

Posted on: Tuesday,  Oct 6, 2015  8:25 AM ET by Stifel

Stifel rated Buy Illumina, Inc. (NASDAQ: ILMN) on 10/06/2015. Previously Stifel rated Buy Illumina, Inc. (NASDAQ: ILMN) on 10/27/2014., when
the stock price was $189.25. Since then, Illumina, Inc. has gained 6.71% as of 01/26/2016's recent price of $201.94.
If you would have followed the previous Stifel's recommendation on ILMN, you would have gained 6.7% of your investment in 456 days.

Illumina, Inc. is a developer, manufacturer and marketer of integrated systems for the large-scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that serve the sequencing, genotyping and gene expression markets. It also, develops and commercializes sequencing technologies used to perform a range of analyses, including whole genome re-sequencing, gene expression analysis and small ribonucleic acid (RNA) analysis. Its customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company operates in two business segments: Life Sciences and Diagnostics. On August 1, 2008, the Company acquired Avantome, Inc. The Company?s subsidiary is Solexa, Inc.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/6/2015 8:25 AM Buy
130.98 175.00
as of 8/27/2015
1 Week down  -4.06 %
1 Month down  -8.52 %
3 Months up  1.51 %
1 YTD down  -3.89 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/28/2015 9:25 AM Buy
210.13 235.00
10/27/2014 8:25 AM Buy
189.25 215.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy